Document is current
Any future updates will be listed below
-
Authors
Pan, Mingjie
Xu, Yueyue
Wang, Yaping
Jiang, Yue
Xie, Yuanyuan
Tai, Chenxu
Wang, Wenqing
Wang, Bin https://orcid.org/0000-0003-3981-8849
-
Funding
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (82070459,82270701)
- License Information
-
More Information
Article History
Received: 30 December 2024
Accepted: 2 May 2025
First Online: 13 May 2025
Declarations
:
: All animal experiments were performed in compliance with the guidelines and regulations from the animal experimentation committee of Nanjing Medical University (Ethics Committee of Nanjing First Hospital). (Project title: To compare the protection of MSC derived from different sources against myocardial infarction; Approval No. DWSY-22115244; Date of approval: 2022-8-25). All procedures involving human-derived materials were granted by the Medical Ethics Committees of Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School. (Project title: Utilization of Clinical Patient Samples (Tissue/Blood/Body Fluids) and Aborted Fetal Tissue to Extract Stem Cells for Basic and Clinical Research in Regenerative Medicine and Treatment of Clinical Diseases; Approval No.2017-161-01; Date of approval: 2017-12-26). All participants provided written informed consent for participation in the study.
: Not applicable.
: The authors declare that they have no competing interests.
